Clinical Trial Update: Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log [NA]

View source ↗

Summary

This clinical trial update discusses a study on discontinuing imatinib in patients with chronic myeloid leukemia in chronic phase who have sustained MR4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Leukemia, Myeloid, Chronic-Phase | NA | Status: UNKNOWN